C4 Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
WATERTOWN, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced that the Company will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 9th at 10:30 am PST (1:30 pm EST).
Related news for (CCCC)
- C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering
- Today’s Top Performers: MoBot’s Market Review 10/16/25 10:00 AM
- 24/7 Market News Snapshot 16 October, 2025 – C4 Therapeutics, Inc. (NASDAQ:CCCC)
- C4 Therapeutics Teams Up with Pfizer on New Myeloma Combo Trial
- From SaaS to Semis: Market Signals Big Moves Ahead
